Registration Successful...
null you have successfully logged registered and logged in

Resources

Information and tools to keep you informed, prepared, and confident

Watch videos and read stories about parents just like you, tap into an extended community of RSV experts and advocates, and find helpful links, answers, and more.

Videos for parents like you

Knowing about severe RSV and how to help protect your high-risk baby is important. It's also good to know you're not the only one going through this.

Learn more about RSV disease and how SYNAGIS can help protect your baby

SYN-+-Your-Baby-Video-copy

Audrey’s story: A family’s struggle with RSV and coverage denial

Audrey-Video-copy

Jessica’s story: A mom who benefited from Cradle with CareSM

jessica-video-image-mobile

Downloads for parents

Downloads for SYNAGIS

Learn more about how SYNAGIS may help your baby (PDF)

Thumbnail-1-copy
Co-Pay-Savings-Card-copy-2

SYNAGIS Information

Key facts about SYNAGIS and how it can help prevent severe RSV disease

Go directly to resources  >

Access & Support

Helpful information about resources available to help pay for SYNAGIS

Go directly to resources  >
SYNAGIS Information
Helpful information about SYNAGIS and RSV

SYNAGIS Brochure

Learning more is a great first step to protecting your baby

Caregiver Action Steps Postcard

Here's what to do when your doctor has prescribed SYNAGIS for your baby

RSV Factsheet

See the main things you should know about RSV disease and SYNAGIS

Access & Support
Useful tools and information to help eligible high-risk infants get SYNAGIS

SYNAGIS CONNECT® Overview

Explains how SYNAGIS CONNECT® can help provide access and support for parents/caregivers and healthcare professionals

Copay Program Overview

Explains a financial assistance program that may reduce out-of-pocket costs for eligible parents/caregivers

Parent/Caregiver Consent Form

Facilitates parent/caregiver authorization to enroll a patient in SYNAGIS CONNECT®

Is SYNAGIS a vaccine?

No. SYNAGIS [si-nah-jis] is an FDA-approved prescription injection of antibodies that is given monthly to help protect high-risk infants from severe RSV disease throughout the RSV season. Each dose provides protection for about 28–30 days.

How many injections of SYNAGIS will my baby need?

Your child's healthcare provider will give you detailed instructions on when SYNAGIS will be given. SYNAGIS is needed every 28-30 days during the RSV season. Each injection of SYNAGIS helps protect your child from severe RSV disease for about 1 month.

My high-risk baby looks healthy. Are monthly injections of SYNAGIS still necessary?

Yes. No matter how your baby looks, they may still be at high risk for severe RSV disease. Your doctor will tell you when RSV season has ended and your baby can stop their monthly injections of SYNAGIS.

Will my high-risk baby need SYNAGIS for a second RSV season?

Most high-risk babies won't need SYNAGIS for a second season. But babies who remain high risk for severe RSV disease in their second year may need SYNAGIS for more than one RSV season. Ask your doctor if your baby will need SYNAGIS for a second season.

Header

Header

What is RSV?

RSV is a seasonal respiratory virus that is easily spread and typically causes mild to moderate cold-like symptoms. But in certain high-risk children, it can cause a serious lung infection.

What is an RSV infection?

RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lungs) and/or pneumonia in children under 1 year of age in the US. In fact, almost all children get RSV before they turn 2 years old.

Learn more about RSV infection >

Is my baby at high risk for severe RSV disease?

Babies born prematurely at 35 weeks or less and children 24 months or younger with certain heart or lung conditions are at high risk for severe RSV disease. In these babies, RSV can lead to hospitalization due to serious lung infections such as bronchiolitis and/or pneumonia.

What is RSV season?

Like the flu, RSV is a seasonal virus. The season varies from one part of the country to the next, but usually starts in fall and continues into spring. In some states such as Alaska, Hawaii, and parts of Texas and Florida, for example, the length of the RSV season may be different. To find out when RSV season starts in your area, talk to your baby's doctor.

How serious is RSV?

Most children with RSV disease suffer only mild to moderate cold-like symptoms. But for some high-risk babies, RSV disease can be more severe. Infants born at 35 weeks or less and children 24 months or younger with certain heart or lung conditions are at high risk for serious lung infections such as bronchiolitis and/or pneumonia.

What are the signs and symptoms of a severe RSV infection?

Some signs and symptoms of severe RSV disease include:

  • Coughing or wheezing that does not stop
  • Fast or troubled breathing
  • A bluish color around the mouth or fingernails
  • Spread-out nostrils and/or a caved-in chest when trying to breathe
  • Gasping for breath

How easy is it to catch RSV?

Like the flu, RSV can be spread by sneezing, coughing or physical contact, such as touching or shaking hands. RSV can live up to 7 hours on countertops and other surfaces. It can spread very quickly in daycare centers and crowded households. As a result, nearly all babies get RSV disease by the age of 2.

What could put my baby at risk for severe RSV disease?

Here are some of the main factors that can increase your baby's risk for severe RSV disease:

  • Premature birth: Infants who are born prematurely (born at 35 weeks or less), and who are 6 months of age or younger at the beginning of RSV season
  • Chronic lung disease: Infants who have a lung condition known as BPD/CLDP (bronchopulmonary dysplasia/chronic lung disease of prematurity) that required medical treatment within the previous 6 months, and who are 24 months of age or younger at the beginning of RSV season
  • Heart disease: Infants who have a heart condition known as HS-CHD (hemodynamically significant congenital heart disease), and who are 24 months of age or younger at the beginning of RSV season

Additional risk factors for premature infants may include:

  • Young chronological age (≤12 weeks of age at the start of RSV season)
  • Pre-school or school-aged sibling(s)
  • Daycare attendance
  • Living with 4 or more family members
  • Family history of wheezing or asthma
  • Exposure to tobacco smoke—never let anyone smoke around your baby
  • Multiple births—twins, triplets, and other multiples are often premature and have a low birth weight
  • Severe disease of muscles or nerves
  • Abnormal airways at birth

Can my baby get RSV more than once?

Yes. RSV is a virus, and just like some other viruses, it is possible for your baby to get RSV disease more than once. After each RSV infection, your baby may become more immune to the virus, but he or she is never completely immune.

There are many preventive measures that you can do to help ensure your baby doesn't get it again.

Learn more >

Is there a cure for RSV disease?

Unfortunately, there is no cure for RSV disease. However, there are several preventive measures you can use to help protect your baby.

Learn more >

Can my baby get RSV in the womb?

No. Your baby cannot get RSV until he or she is born.

INDICATION AND IMPORTANT SAFETY INFORMATION


open isi

What is SYNAGIS® (palivizumab)?

SYNAGIS is a prescription medication that is injected (50 mg and 100 mg) in certain children to help prevent serious lung disease caused by respiratory syncytial virus (RSV). You should know that SYNAGIS is used to prevent RSV, and not to treat children who already have RSV, including children:

  • born prematurely (at or before 35 weeks) and who are 6 months of age or less at the beginning of RSV season

INDICATION AND IMPORTANT SAFETY INFORMATION

What is SYNAGIS® (palivizumab)?

SYNAGIS is a prescription medication that is injected (50 mg and 100 mg) in certain children to help prevent serious lung disease caused by respiratory syncytial virus (RSV). You should know that SYNAGIS is used to prevent RSV, and not to treat children who already have RSV, including children:

  • born prematurely (at or before 35 weeks) and who are 6 months old or younger at the beginning of RSV season
  • diagnosed with a chronic lung condition called bronchopulmonary dysplasia (BPD) that needed medical treatment within the last 6 months and who are 24 months old or younger at the beginning of RSV season
  • born with certain types of heart disease and who are 24 months old or younger at the beginning of RSV season

You Should Know: It is not known if SYNAGIS is safe and works in children who are over 24 months old when they started taking SYNAGIS.

IMPORTANT SAFETY INFORMATION

You Should Know: SYNAGIS may cause severe allergic reactions.

  • Signs and symptoms of a severe allergic reaction could include:
    • Severe rash, hives, or itchy skin
    • Swelling of the lips, tongue, face, or throat or difficulty swallowing
    • Difficult, rapid, or irregular breathing
    • Bluish color of skin, lips, or under fingernails
    • Muscle weakness or floppiness
    • Unresponsiveness

Call the child’s healthcare provider or get medical help right away if the child has any of the signs or symptoms of a severe allergic reaction after getting SYNAGIS. They can be life threatening or cause death.

You Should Know: SYNAGIS is given by injection. If the child has a problem with bleeding or bruises easily, an injection could cause a problem.

Before the child takes SYNAGIS, you should tell the child’s healthcare provider about all their medical conditions and medicines including vitamins, supplements, and herbal remedies.

What are the possible side effects of SYNAGIS?

The most common side effects are fever and rash.

You Should Know: These are not all the possible side effects for SYNAGIS. For more information, ask the child’s healthcare provider or review the full Prescribing Information for SYNAGIS, including Patient Information.

If you suspect that a child has experienced a side effect, call the child’s healthcare provider. You may also report side effects to Sobi North America at 1-866-773-5274 or the US Food and Drug Administration (FDA) at 1-800-FDA-1088.

backtotop
 
 

Contact Us X

AstraZeneca has transferred all rights to SYNAGIS (palivizumab) to another manufacturer, Swedish Orphan Biovitrum AB (SOBI), in January of 2019. If you need SYNAGIS support, please contact SYNAGIS CONNECT® at (866)-285-8419(866)-285-8419.

RSV=respiratory syncytial virus.
All imagery is for illustrative purposes only.